Glomerular filtration rate (eGFR), acute kidney injury, fractional excretion, and dialysis indices.
Predicts serum Na change per liter of IV fluid: (infusate Na - serum Na)/(TBW + 1).
Holliday-Segar maintenance fluid requirements.
Identifies the likelihood of acute interstitial nephritis in at-risk patients undergoing kidney biopsy evaluation. Uses commonly available clinical and laboratory parameters to predict AIN probability.
Classifies severity of acute kidney injury based on serum creatinine and urine output criteria within 48 hours
The serum anion gap (Na⁺ − (Cl⁻ + HCO₃⁻)) screens for high–anion-gap metabolic acidosis. An elevated gap indicates unmeasured anions and prompts evaluation for causes such as lactic acidosis, ketoacidosis, or toxic ingestions.
Corrects anion gap for hypoalbuminemia: corrected AG = AG + 2.5x(4.0 - albumin).
Calculates fluid balance from sodium concentrations indicating 0.9% saline fluid, and free water losses (GI, urine, etc) and gains (IV fluids, PO, etc). Helps track complex fluid dynamics in hospitalized patients by accounting for different sodium concentrations in various fluids.
Evaluates kidney function by calculating the ratio of blood urea nitrogen (BUN) to serum creatinine, helping to distinguish between prerenal, intrinsic renal, and postrenal causes of kidney dysfunction.
Predicts the risk of acute kidney injury in patients treated with intravenous cisplatin. This calculator estimates the probability of moderate to severe AKI (≥2-fold rise in serum creatinine or need for kidney replacement therapy within 14 days of cisplatin administration).
CKD-EPI 2021 equation to estimate glomerular filtration rate (eGFR) based on serum creatinine, age, and sex. This 2021 version removed the race component from the original equation.
Determines likelihood of HIV patients developing CKD in the next 5 years, whether they take tenofovir or not
Estimates glomerular filtration rate based on creatinine and/or cystatin C in patients aged 1 to 25 years
Creatinine clearance by the Cockcroft-Gault equation: CrCl = ((140 − age) × weight × (0.85 if female)) / (72 × SCr). Estimates renal function for drug dosing; uses actual body weight unless otherwise specified by the drug monograph.
Calcium corrected for hypoalbuminemia using SI units.
Glucose-corrected serum sodium (Katz correction).
Estimates creatinine clearance for kidney function assessment and medication dosing using patient demographics and serum creatinine
Measured CrCl from timed urine collection.
eGFR from cystatin C via the CKD-EPI 2012 cystatin C equation: 133 × min(Scys/0.8,1)^−0.499 × max(Scys/0.8,1)^−1.328 × 0.996^age × 0.932 (if female). Useful when creatinine is unreliable (extremes of muscle mass, vegetarian diet). Scys in mg/L; result in mL/min/1.73m².
eGFR via two published equations: CKD-EPI 2021 (race-free; 142 × min(SCr/κ,1)^α × max(SCr/κ,1)^−1.200 × 0.9938^age × 1.012 if female) and the 4-variable MDRD (175 × SCr^−1.154 × age^−0.203 × 0.742 if female × 1.212 if Black). SCr in mg/dL; results in mL/min/1.73m².
Bedside estimate of urine ammonium from the urine osmolal gap.
Determines if renal failure is due to pre-renal or intrinsic pathology. Calculates the percentage of filtered sodium that is excreted in the urine.
Determines the cause of renal failure. Similar to FENa, but can be used in patients on diuretics. More sensitive and specific than FENa for differentiating prerenal azotemia from acute tubular necrosis.
Calculates free water deficit by estimated total body water in patients with hypernatremia or dehydration
Corrects measured serum sodium for hyperglycemia (Hillier 1.6 factor).
Predicts serum sodium change per liter of infusate to plan safe hyponatremia correction.
Predicts risk of 50% decline in eGFR or end-stage kidney disease in patients with IgA nephropathy. This validated prediction tool was developed using an international multi-ethnic cohort of 2,781 patients with biopsy-proven idiopathic IgA nephropathy. The tool uses clinical, laboratory, and histological parameters available at biopsy to provide risk estimates for kidney function decline. Two versions are available: one including race/ethnicity and one without race. The tool is endorsed by the 2021 KDIGO guidelines as the preferred method to predict kidney outcomes in IgA nephropathy patients. It facilitates clinical decision-making, patient counseling, and clinical trial enrollment by stratifying patients based on their risk of progressive kidney disease.
KDIGO acute kidney injury staging (2012) from serum creatinine change and urine output: Stage 1 (SCr 1.5-1.9× baseline or ≥0.3 mg/dL rise; UO <0.5 mL/kg/h for 6-12 h), Stage 2 (SCr 2.0-2.9×; UO <0.5 for ≥12 h), Stage 3 (SCr 3.0× or ≥4.0 mg/dL or RRT; UO <0.3 for ≥24 h or anuria ≥12 h). Stage = worst of the creatinine and urine-output criteria.
CKD prognosis by GFR category (G1-G5) and albuminuria category (A1-A3).
Predicts progression to kidney failure (dialysis or transplantation) in patients with CKD stages 3-5 using age, sex, eGFR, and urine albumin/creatinine ratio. Validated in over 700,000 individuals across 30+ countries.
Estimates GFR in patients with acutely changing creatinine levels, allowing for earlier detection of acute kidney injury when creatinine is in a non-steady state. More accurate than traditional GFR equations during periods of rapidly changing kidney function.
Kinetic GFR (Chen) for unstable renal function: kGFR = (B × SSPCr / MeanPCr) × (1 − (24 × ΔPCr) / (Δt × MaxΔPCr/Day)), where B is the baseline Cockcroft-Gault clearance at the steady-state creatinine, and MaxΔPCr/Day is the theoretical maximum daily creatinine rise (production/Vd). Accounts for the lag between GFR change and creatinine change.
Quantifies adequacy of both hemodialysis and peritoneal dialysis treatment using the Daugirdas second-generation equation to assess urea clearance and dialysis effectiveness
Predicts likelihood of hydronephrosis on renal ultrasound (RUS) requiring urological intervention in adult patients with acute kidney injury
Predicts mortality or acute kidney injury (AKI) requiring renal replacement therapy in hospitalized rhabdomyolysis patients. The score helps identify low-risk patients unlikely to have severe adverse outcomes.
Estimates glomerular filtration rate (GFR) based on serum creatinine and patient characteristics for chronic kidney disease (CKD) assessment. The MDRD equation was developed from the Modification of Diet in Renal Disease study.
Calculates measured creatinine clearance from a timed urine collection (usually 24 hours): CrCl = (urine creatinine × urine volume) / (serum creatinine × collection time). Covers both conventional (mg/dL) and SI (µmol/L) units.
Calculated osmolality and osmolar gap; gap > 10 suggests unmeasured osmoles (toxic alcohols).
Classifies peritoneal membrane transport type from the 4-hour dialysate-to-plasma creatinine ratio.
RIFLE: Risk, Injury, Failure, Loss, ESKD based on creatinine rise, urine output and duration.
Calculate serum osmolality from sodium, BUN, glucose (and ethanol).
Corrects measured sodium for hyperglycemia: +1.6 per 100 mg/dL glucose above 100 (2.4 if >400).
Total body sodium deficit: (desired Na - serum Na) x TBW.
Estimates total body water (TBW) from body weight using standard physiologic fractions: ~60% of body weight in adult men, ~50% in adult women. Bedside approximation for fluid and electrolyte planning.
Evaluates renal potassium handling in patients with hyperkalemia or hypokalemia by estimating the ratio of potassium in the cortical collecting duct to that in the peritubular capillaries.
Measures hemodialysis adequacy from pre- and post-dialysis BUN.
Quantifies 24h proteinuria with protein/creatinine ratio in single urine sample. Provides a convenient alternative to 24-hour urine collection for estimating daily protein excretion in patients with stable renal function.
KDIGO albuminuria categories from the urine albumin-to-creatinine ratio (ACR): A1 <30 mg/g (normal to mildly increased), A2 30-300 mg/g (moderately increased), A3 >300 mg/g (severely increased). Used with eGFR for CKD staging and prognosis.
Detects urinary acidosis for evaluation of non-anion gap metabolic acidosis. Helps differentiate between renal and extrarenal causes of normal anion gap metabolic acidosis by assessing urinary ammonium excretion capacity.
Estimates expected 24-hour urine creatinine excretion from body weight: ~20-25 mg/kg/day in men, ~15-20 mg/kg/day in women. Used to verify completeness of a 24-hour urine collection (measured excretion far below expected suggests under-collection).
Urine osmolal gap: measured urine osmolality minus calculated urine osmolarity [2×(Na+K) + urea_N/2.8 + glucose/18]. Estimates unmeasured urinary osmoles (chiefly ammonium); used in the workup of normal-anion-gap metabolic acidosis to distinguish renal from extrarenal bicarbonate loss.
Calculates 24-hour urine output rate and fluid balance for assessment of renal function and fluid status. Helps identify oliguria, polyuria, and fluid imbalances in hospitalized patients.
Estimates 24-hour urine protein excretion from a spot urine protein-to-creatinine ratio (UPCR): the ratio in mg/mg approximates grams of protein excreted per day. Screening and monitoring tool for proteinuria.
Watson formula for female total body water.
Estimates male total body water (Watson formula).
Clinical Decision Support (CDS) Notice & Legal Disclaimer
All calculations and clinical scoring tools in this directory are intended strictly for educational and decision-support use by licensed medical practitioners. They do not constitute autonomous medical advice or direct treatment orders. See the full DexaMed Medical Disclaimer.